WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HF 1470

Summary: HF 1470 (Minnesota) – Members added to opioids, substance use, and addiction subcabinet

Purpose and intent

HF 1470 proposes to expand membership of Minnesota’s opioids, substance use, and addiction subcabinet. The bill aim is to broaden the leadership and advisory capacity overseeing state efforts to address opioids, substance use disorders, and related addiction issues. By adding additional members, the bill seeks to enhance coordination across agencies and stakeholders, improve decision-making, and strengthen the state’s ability to respond to substance use challenges.

Key provisions

  • Expansion of subcabinet membership: The central feature is to add specific individuals or roles to the existing opioids, substance use, and addiction subcabinet. The bill does not specify in the summary which exact positions are added, but the intent is to broaden representation on the subcabinet beyond its current composition.
  • Authority and scope retained: The subcabinet would continue to function as a coordinating body within the executive branch, aligning policy development, program delivery, and resource allocation related to opioids, substance use, and addiction issues.
  • Relation to existing governance framework: HF 1470 operates within Minnesota’s established structure for addressing opioids and addiction, leveraging the subcabinet as a mechanism to unify efforts across state agencies, health services, criminal justice, public safety, and related sectors.

Note: The bill text would specify exact additions to membership and any related duties, reporting requirements, or sunset/renewal provisions. The summary here focuses on the broad change—adding members to the subcabinet—and the intended governance impact.

Affected parties and impact

  • State agencies and officials: Agencies involved in health, public safety, human services, judiciary, and related fields would participate through the expanded subcabinet membership, potentially improving cross-agency collaboration.
  • Partners and stakeholders: Healthcare providers, addiction treatment organizations, public health groups, communities affected by substance use, and advocacy organizations may experience more coordinated state guidance and policy initiatives as a result of expanded leadership.
  • Policy and program implementation: With more members, the subcabinet could facilitate faster consensus on priorities, streamline funding decisions, and improve oversight of opioid and addiction-related programs.

Procedural and timeline aspects

  • Legislative action history:
    • February 24, 2025: Introduction and first reading; referred to the State Government Finance and Policy committee.
    • February 26, 2025: Author added Virnig (indicating an amendment or additional sponsor’s action).
  • Next steps (typical process): If advanced, HF 1470 would go through committee hearings, potential amendments, and votes in the Minnesota House of Representatives, then move to the Senate. If enacted, the changes would take effect as specified in the bill’s provisions, potentially on a defined effective date.

Notes for readers

  • The summary reflects the bill’s core aim to broaden subcabinet membership related to opioids, substance use, and addiction. Specific names, roles added, or procedural details would be clarified in the enacted bill text or committee statements.
  • For readers monitoring implementation, key questions would include: who exactly is added to the subcabinet, what new duties or reporting requirements accompany membership changes, and how the expansion affects funding decisions and program coordination.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.